The researchers found that single-nucleotide polymorphisms (SNPs) in the SMAD2 and TGFBR2 genes were associated with an increased risk of MS, both independently and through complex gene–gene interactions. This evidence concerns the gene TGFBR2 and myeloid sarcoma.